Cinctive Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-139,388
| Closed | -$12.5M | – | 416 |
|
2023
Q3 | $12.5M | Buy |
139,388
+81,086
| +139% | +$7.26M | 0.62% | 34 |
|
2023
Q2 | $4.96M | Sell |
58,302
-116,823
| -67% | -$9.95M | 0.17% | 177 |
|
2023
Q1 | $14.5M | Buy |
175,125
+104,635
| +148% | +$8.66M | 0.48% | 49 |
|
2022
Q4 | $5.54M | Sell |
70,490
-90,036
| -56% | -$7.08M | 0.27% | 107 |
|
2022
Q3 | $11.9M | Buy |
+160,526
| New | +$11.9M | 0.5% | 44 |
|
2021
Q4 | – | Sell |
-54,351
| Closed | -$3.84M | – | 549 |
|
2021
Q3 | $3.84M | Buy |
54,351
+38,592
| +245% | +$2.72M | 0.19% | 177 |
|
2021
Q2 | $1.05M | Buy |
+15,759
| New | +$1.05M | 0.05% | 346 |
|
2021
Q1 | – | Sell |
-37,733
| Closed | -$4.48M | – | 439 |
|
2020
Q4 | $4.48M | Buy |
37,733
+16,649
| +79% | +$1.98M | 0.37% | 108 |
|
2020
Q3 | $1.84M | Buy |
+21,084
| New | +$1.84M | 0.16% | 213 |
|